Stay updated on BI 695501 vs Adalimumab in Active RA Clinical Trial
Sign up to get notified when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.

Latest updates to the BI 695501 vs Adalimumab in Active RA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a minor release of the site software without any change to the displayed study record.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.5.0 added. Revision: v3.4.3 removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no substantive changes to the study details.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page shows an updated site revision to v3.4.2, and the prior funding-status notice (v3.4.1) has been removed.SummaryDifference0.2%

- Check94 days agoChange DetectedA government funding notice about potential delays and NIH operations has been added to the page, and the revision shows v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BI 695501 vs Adalimumab in Active RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.